Background and Objective Mutations in the MAPT gene cause frontotemporal dementia
(FTD). Most previous studies investigating the neuroanatomical signature of MAPT …

Objective To characterize the time course of ventricular volume expansion in genetic
frontotemporal dementia (FTD) and identify the onset time and rates of ventricular expansion …

Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal
dementia (FTD) are underway, but sensitive cognitive outcome measures are lacking. The …

Background Semantic and socioemotional knowledge, including person recognition, can be
altered in frontotemporal dementia (FTD), and is often associated with the right temporal …

Background Clinical endpoints for upcoming therapeutic trials in frontotemporal dementia
(FTD) are increasingly urgent. Cognitive composite scores are often used as endpoints but …

Background In patients with frontotemporal dementia, it has been shown that brain atrophy
occurs earliest in the anterior cingulate, insula and frontal lobes. We used visual rating …

Background Mutations in the MAPT gene are known to cause frontotemporal dementia
(FTD), but there is heterogeneity in FTD phenotype across individuals. Here we used an …

Background Previous research in genetic frontotemporal dementia (FTD) has suggested that
the FTD Rating Scale (FRS) may be a more sensitive measure of disease severity than the …

Background and objectives The C9orf72 expansion is the most common genetic cause of
frontotemporal dementia (FTD) and/or motor neuron disease (MND). Corticospinal …

Introduction We aimed to assess episodic memory in genetic frontotemporal dementia (FTD)
with the Free and Cued Selective Reminding Test (FCSRT). Methods The FCSRT was …